Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AKTX | US
0.02
0.52%
Healthcare
Biotechnology
30/06/2024
30/08/2024
3.83
3.75
3.85
3.75
Akari Therapeutics Plc a clinical-stage biopharmaceutical company focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities including paroxysmal nocturnal hemoglobinuria Guillain-Barré syndrome hematopoietic stem cell transplant-associated thrombotic microangiopathy and bullous pemphigoid as well as pre-clinical program developing long-acting PASylated-nomacopan for treatment of geographic atrophy secondary to dry age-related macular degeneration. The company is based in London the United Kingdom.
View LessLow Debt to Equity (< 0.25)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
44.1%1 month
82.1%3 months
129.4%6 months
118.2%-
-
3.07
-0.27
0.20
-0.06
-
-
-18.08M
45.78M
45.78M
-
-
-
-
-1.28K
1.77
0.32
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.99
Range1M
1.16
Range3M
2.78
Rel. volume
0.09
Price X volume
5.63K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Zivo Bioscience Inc | ZIVO | Biotechnology | 14.94 | 50.29M | 32.21% | n/a | -2.22% |
Anebulo Pharmaceuticals Inc. Common Stock | ANEB | Biotechnology | 1.92 | 49.79M | 5.14% | n/a | 0.00% |
Reneo Pharmaceuticals Inc. Common Stock | RPHM | Biotechnology | 1.48 | 49.47M | -1.33% | n/a | 1.07% |
Rallybio Corporation Common Stock | RLYB | Biotechnology | 1.15 | 47.71M | -3.36% | n/a | 0.35% |
Fortress Biotech Inc | FBIO | Biotechnology | 2.03 | 46.31M | -0.98% | n/a | 494.61% |
LAVA Therapeutics BV | LVTX | Biotechnology | 1.75 | 46.02M | -4.37% | n/a | 14.37% |
CALC | CALC | Biotechnology | 4.17 | 44.83M | -3.02% | n/a | 0.00% |
Aadi Bioscience Inc | AADI | Biotechnology | 1.81 | 44.55M | 3.43% | n/a | 1.34% |
CARM | CARM | Biotechnology | 1.07 | 44.45M | -1.83% | n/a | 0.00% |
Lantern Pharma Inc. | LTRN | Biotechnology | 4.09 | 44.03M | 1.24% | n/a | 0.71% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3.68 | 39.85M | -1.12% | n/a | 54.96% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.34 | 28.51M | 13.04% | n/a | 16.03% |
ILAG | ILAG | Building Products & Equipment | 1.25 | 22.57M | 6.84% | n/a | 5.48% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 0.6131 | 18.67M | -4.20% | n/a | 204.46% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2495 | 3.93M | 5.94% | n/a | 0.00% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.391 | 3.72M | -6.28% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.45 | 3.70M | 13.28% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.47 | 2.11M | -7.84% | n/a | 0.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.06 | 0.97 | Cheaper |
Ent. to Revenue | - | 3,681.29 | - |
PE Ratio | - | 39.83 | - |
Price to Book | 3.07 | 14.54 | Cheaper |
Dividend Yield | - | 2.19 | - |
Std. Deviation (3M) | 129.35 | 76.13 | Riskier |
Debt to Equity | -0.27 | -2.05 | Expensive |
Debt to Assets | 0.20 | 0.25 | Cheaper |
Market Cap | 45.78M | 4.04B | Emerging |